Using AI to treat rare diseases
Dr. Neil Thompson says rare disease treatment can be transformed by AI and learning lessons from the COVID-19 response
Dr. Neil Thompson
Creating A Pathway To Hope
Gilead Science’s PrEP Hub® platform is a gamechanger in the fight against HIV – both the disease and the stigma.
JPMorgan: Walking The Walk
JPMorgan Chase & Co’s Tech For Social Good team is celebrating 10 years of doing good, impacting thousands of non-profits and empowering its own workforce.
Can cultivated meat help save the planet?
How lab-grown-meat startups are aiming to take both the guilt and the carbon impact out of food.
Breaking digital barriers
Nikki Labrum and Freddie Quek discuss the impact of the digital divide and how to ensure no child is ever left behind
Battling burnout: How AI can help reduce alert fatigue
AI can help alleviate cybersecurity alert fatigue by correlating events, qualifying threats, and reducing stress for analysts, improving well-being and addressing the skills gap in SOCs.
Your teams are neurodiverse. It’s time to embrace neuroinclusion.
Tech leaders may already know their teams are rich in neurodiversity, but keeping hold of them means intentional action.
Gemma McCall
Gemma McCall is CEO of Culture Shift, which has built a reporting platform to identify and prevent harassment and bullying. In this podcast, Gemma discusses the role of technology and data in overcoming this problem.
Creating a pathway to hope
HIV prevention drugs have helped reduce infection rates globally. Now Gilead Sciences has rolled out its digital platform, PrEP Hub® , in the US with a mission to help improve access to drugs and reduce stigma among the communities that most need it.
We find out why it’s a gamechanger in the fight against HIV.
Dr. Neil Thompson
Using AI to treat rare diseases
Dr. Neil Thompson says rare disease treatment can be transformed by AI and learning lessons from the COVID-19 response